RA Capital Management
Investment Details
Investor Type
Private Equity
Asset Class Focus
Private Equity, Venture Capital, Hedge Funds
Stage Focus
Seed, Early Stage, Series A, Series B, Growth, Late Stage, Pre-IPO, Buyout, Turnaround, Distressed
Geographical Focus
United States, United Kingdom, Canada, Germany, Japan, Australia, Singapore, China, India, Brazil, France, Switzerland, Mexico, South Korea, South Africa, Israel, Chile, Argentina, Colombia, Peru
Industries Focus
- Financial Services
- Technology
- Healthcare
- Energy
- Consumer Goods
- Media
- Agriculture
- Healthcare Services
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Manufacturing
- Biotechnology
- Environmental Services
- Research Tools
Investment Size:
1,000,000 to 500,000,000 USD
Investor Details Founded: 2004
RA Capital Management is a multi-stage investment firm based in Boston, Massachusetts, dedicated to evidence-based investing in public and private healthcare and life sciences companies. The firm focuses on developing drugs, medical devices, diagnostics, services, and research tools, supporting companies from seed stage to public markets. RA Capital's internal research division, TechAtlas, analyzes scientific and clinical data to inform investment decisions, while its healthcare incubator, Raven, offers entrepreneurs a collaborative platform to build innovative companies. As of March 2025, the firm manages over $12.6 billion in assets and employs approximately 130 professionals. RA Capital's portfolio includes investments in various therapeutic areas, reflecting its commitment to advancing healthcare solutions globally.
Requirements
- Evidence-based scientific approach
- Strong management teams
- Innovative technologies
- Scalable business models
- Global market potential
- Regulatory compliance
- Clear exit strategies
- Alignment with RA Capital's mission and values
- Commitment to improving patient outcomes
- Sustainable financial performance
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Moderna
- Alnylam Pharmaceuticals
- Editas Medicine
- Sarepta Therapeutics
- Vertex Pharmaceuticals
- T2 Biosystems
- Alector
- Kura Oncology
- Cerevel Therapeutics
- Axcella Health
- CureVac
- Beam Therapeutics
- Sana Biotechnology
- Arcellx
- CureMetrix
- Foghorn Therapeutics
- Imara
- Keros Therapeutics
- Mersana Therapeutics
- Sutro Biopharma
Mentioned In
Claim this Investor
Are you an official representative of RA Capital Management?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim